M. J. Crossley, S. Perrier et al.
[D5]pyridine): d = 171.1 (acetate C=O), 150.0 (a-pyrrole), 144.1 (phenyl
ipso), 143.6 (triazole C4), 135.3 (phenyl Cortho), 133.6 (phenyl Cpara), 131.8
(b-pyrrole), 126.1 (phenyl Cmeta), 124.1 (triazole C5), 119.8 (porphyrin
meso), 57.8 (triazole-HCa), 54.3 (triazole-HNa), 21.0 ppm (acetate CH3).;
ACHTUNGTRENNUNG
C
C
IR (ATR, solid film): nmax = 2923, 2852, 2246, 1736, 1223, 993, 906, 796,
782, 720, 646 cmꢀ1; UV/Vis (0.124m pyridine in CHCl3): lmax (log10(e)) =
409 (4.64), 430 (5.71), 563 (4.29), 603 nm (4.02); UV/Vis (CHCl3): lmax
(log10(e)) = 400 (4.57), 420 (5.66), 548 (4.30), 586 nm (3.68); HRMS
(MALDI-FTICR): m/z: calcd for: 1311.36507; found: 1311.36537
[M+Na]+; MS (MALDI-FTICR): m/z (%): 1311.37 [M+Na]+ (20),
1249.45 [M+HꢀC2H3O]+ (100), 1227.47 [MꢀZn]+ (40).
358H, backbone -CH2CH- and -S-CH
2ACHTUGNTREN[UNGN CH2]CH3), 0.92 ppm (brm, 24H,
-S(CH2)3-CH3 and -O(C=O)CHCH3); IR (DRIFTS, KBr matrix): nmax =
A
U
3077, 3060, 3025, 2924, 2852, 1944, 1874, 1804, 1734, 1601, 1493, 1452,
1157, 1028, 908, 756, 698 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 312
(4.75), 404 (4.56), 425 (5.67), 484 (3.26), 518 (3.47), 557 (4.24), 596 nm
(3.81).
Zinc(II) di(triazolyl acetate)porphyrin, (TA)2–Zn: A 5 mL microwave
tube was charged with DN3PP–Zn (10.0 mg, 15.7 mmol), sodium ascor-
bate (5.5 mg, 28 mmol), propargyl acetate (0.37 mL, 95 mm solution in
THF), copper(II) sulfate (1.2 mg, 4.7 mmol), and DMF (2 mL). The con-
tent of the tube was sonicated briefly to obtain a homogeneous purple
solution, then a magnetic stirrer bar was added and the tube sealed. The
reaction was heated under microwave irradiation (100 W, 1008C) for
25 min, then allowed to cool to room temperature. Work-up was per-
formed as for (TA)4–Zn to yield the product as a dark purple solid resi-
due (12.5 mg, 97%). M.p. >3008C; 1H NMR (500 MHz, CDCl3/TMS +
15% v/v [D5]pyridine): d = 10.23 (s, 2H, meso-H), 9.38 (d, J=4.5 Hz,
4H, b-pyrrolic H), meso-H), 9.03 (d, J=4.5 Hz, 4H, b-pyrrolic H), 8.24
(d, J=8.0 Hz, 4H, phenyl Ho), 7.93 (s, 2H, triazole H), 7.65 (d, J=
8.0 Hz, 4H, phenyl Hm), 5.88 (s, 4H, Na-triazole CH2), 5.35 (s, 4H, Ca-tri-
azole CH2), 2.13 ppm (s, 6H, acetate CH3); 13C NMR (125 MHz, CDCl3/
TMS + 15% v/v [D5]pyridine): d = 170.9 (acetate C=O), 149.7 (pyrrole),
149.5 (pyrrole), 144.0 (phenyl Cipso), 143.5 (triazole C4), 133.5 (phenyl
AHCTUNGTRENNUNG
(PS40)4–Zn: Mn,GPC (THF)=15250 gmolꢀ1; ꢀ=1.25; 1H NMR (300 MHz,
CDCl3/TMS + 2% v/v [D5]pyridine): d = 8.77 (brs, 8H, b-pyrrolic H),
8.13 (brs, 8H, phenyl Ho), 7.67 (brm, 4H, triazole Ar-H), 7.51 (brs, 8H,
phenyl Hm), 7.25–6.25 (brm, 800H, polystyrene Ar-H), 5.76 (brm, 8H,
triazole-HNa), 5.11–5.00 (brm, 8H, triazole-HCa), 4.87–4.73 (brm, 4H,
-CH-SCS2), 3.24 (brs, 8H, -SCH2CH2-), 1.86–1.08 (brm, 478H, backbone
-CH2CH- and -S-CH
2ACHTUNGTRNE[UNG CH2]CH3), 0.90 ppm (brm, 24H, -SCAHUTGNTREN(NUGN CH2)3-CH3 and
-O(C=O)CHCH3); IR (DRIFTS, KBr matrix): nmax = 3077, 3060, 3025,
AHCTUNGTRENNUNG
2924, 2852, 1944, 1874, 1805, 1734, 1601, 1493, 1452, 1157, 1028, 756,
698 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 312 (4.74), 404 (4.56), 425
(5.67), 485 (3.27), 517 (3.48), 557 (4.24), 596 (3.81), 642 nm (2.48).
(PS20)2–Zn: Mn,GPC (THF)=5170 gmolꢀ1; ꢀ=1.18; 1H NMR (500 MHz,
AHCTUNGTRENNUNG
CDCl3/TMS + 2% v/v [D5]pyridine): d = 10.23 (s, 2H, porphyrin meso-
H), 9.37 (brs, 4H, b-pyrrolic H), 9.01 (brm, 4H, b-pyrrolic H), 8.24
(brm, 4H, phenyl Ho), 7.71 (brm, 2H, triazole Ar-H), 7.61 (brs, 4H,
phenyl Hm), 7.45–6.30 (brm, 200H, polystyrene Ar-H), 5.84 (brm, 4H,
triazole-HNa), 5.18 (brm, 4H, triazole-HCa), 4.97–4.72 (brm, 2H, -CH-
SCS2), 3.27 (brs, 4H, -SCH2CH2-), 2.58–1.16 (brm, 124H, backbone
C
ortho), 132.0 (phenyl Cpara), 131.8 (pyrrole), 126.1 (phenyl Cmeta), 124.0
(triazole C5), 118.4 (porphyrin Cmeso), 106.0 (pyrrole), 57.8 (triazole-HCa),
54.3 (triazole-HNa), 20.9 ppm (acetate CH3); IR (DRIFTS, KBr matrix):
nmax = 2923, 2852, 1739, 1518, 1439, 1394, 1366, 1236, 1146, 1119, 1058,
996, 850, 823, 781, 729, 702 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 313
(4.25), 353 (4.05), 393, (4.63), 413 (5.72), 451 (3.19), 504 (3.45), 543
(4.31), 581 nm (3.54); HRMS (MALDI-FTICR): m/z: calcd for:
831.21287; found: 831.21236 [M+H]+; MS (MALDI-FTICR): m/z (%):
831.21 [M+H]+ (10), 747.53 [M+Hꢀ2ꢂCOCH3]+ (100).
-CH2CH- and -S-CH
2ACHTUNGTRNE[UNG CH2]CH3), 0.92 ppm (brm, 12H, -SCAHUTGNTREN(NUGN CH2)3-CH3 and
-O(C=O)CHCH3); IR (DRIFTS, KBr matrix): nmax = 3080, 3061, 3025,
AHCTUNGTRENNUNG
2926, 1944, 1870, 1804, 1735, 1600, 1493, 1453, 1370, 1157, 1066, 1027,
999, 907, 757, 699 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 312 (4.37), 392
(4.42), 413 (5.47), 451 (3.57), 505 (3.40), 543 (4.12), 580 (3.40), 633 nm
(2.73).
AHCTUNGTRENNUNG
(PS30)2–Zn: Mn,GPC (THF)=7150 gmolꢀ1; ꢀ=1.19; 1H NMR (500 MHz,
CDCl3/TMS + 2% v/v [D5]pyridine): d = 10.13 (s, 2H, porphyrin meso-
H), 9.27 (brs, 4H, b-pyrrolic H), 8.91 (brm, 4H, b-pyrrolic H), 8.15
(brm, 4H, phenyl Hi), 7.63 (brm, 2H, triazole Ar-H), 7.52 (brs, 4H,
phenyl Hn), 7.17–6.30 (brm, 300H, polystyrene Ar-H), 5.75 (brm, 4H, tri-
azole-HNa), 5.07 (brm, 4H, triazole-HCa), 4.97–4.72 (brm, 2H, -CH-SCS2-
), 3.17 (brs, 4H, -SCH2CH2-), 2.58–1.16 (brm, 184H, backbone -CH2CH-
General Procedure for PPC synthesis: Synthesis of ACTHNUGTRNEUNG(PS30)4–Zn is descri-
bed. Azidoporphyrin TN3PP–Zn (10 mg, 11 mmol), alkyne-functionalised
RAFT polystyrene (DP=30, 147 mg, 49.0 mmol), copper(II) sulfate pen-
tahydrate (1.7 mg, 6.7 mmol) and sodium ascorbate (7.7 mg, 39 mmol)
were weighed into a 5 mL sealable microwave tube. DMF (3 mL) and a
magnetic stirrer bar was added and the vessel sealed. The reaction mix-
ture was sonicated briefly, then heated under microwave irradiation
(100 W, 1008C) for 25 min then allowed to cool. Work-up procedure con-
sisted of passing the crude reaction mixture directly through a short alu-
mina column (Brockmann grade I), then diluting with ethyl acetate (ca.
20 mL) and washing the organic phase with deionised water (5ꢂ50 mL)
to remove the DMF. The organic layer was dried over Na2SO4, filtered
and the solvents removed on a rotary evaporator. The resulting amor-
phous purple solid was dissolved in minimal CH2Cl2 and precipitated by
dropwise addition into methanol at ꢀ788C to afford the purified polymer
as a pale purple powder. For two-arm conjugates, the amount of polymer,
catalyst and reducing agent was halved, but reaction volume remained
constant.
and -S-CH2ACHTUNGTERN[NGUN CH2]CH3), 0.80 ppm (brm, 12H, -SAHCTNURTGEGN(NNU CH2)3-CH3 and -OACHTUNGTRENNUNG(C=
O)CHCH3); IR (DRIFTS, KBr matrix): nmax = 3080, 3061, 3025, 2926,
1944, 1870, 1804, 1735, 1600, 1493, 1453, 1370, 1157, 1066, 1027, 999, 907,
757, 699 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 312 (4.37), 393 (4.31), 413
(5.38), 451 (3.41), 505 (3.34), 543 (4.02), 580 (3.35), 634 nm (2.89).
AHCTUNGTRENNUNG
(PS40)2–Zn: Mn,GPC (THF)=10200 gmolꢀ1; ꢀ=1.25; 1H NMR (500 MHz,
CDCl3/TMS + 2% v/v [D5]pyridine): d = 10.13 (s, 2H, porphyrin meso-
H), 9.27 (brs, 4H, b-pyrrolic H), 8.91 (brm, 4H, b-pyrrolic H), 8.15 (brd,
J=6.7 Hz, 4H, phenyl Ho), 7.63 (brm, 2H, triazole Ar-H), 7.53 (brd, J=
7.0 Hz, 4H, phenyl Hm), 7.24–6.16 (brm, 400H, polystyrene Ar-H), 5.75
(brm, 4H, triazole-HNa), 5.07 (brm, 4H, triazole-HCa), 4.97–4.72 (brm,
2H, -CH-SCS2), 3.17 (brs, 4H, -SCH2CH2-), 2.58–1.16 (brm, 184H, back-
bone -CH2CH- and -S-CH
2ACHTUNGTREN[UNG CH2]CH3), 0.80 ppm (brm, 12H, -SACHTUNGTRENNUNG(CH2)3-
ACHTUNGTRENNUNG
(PS20)4–Zn: Mn,GPC (THF)=9400 gmolꢀ1; ꢀ=1.30; 1H NMR (500 MHz,
CH3 and -O(C=O)CHCH3); IR (DRIFTS, KBr matrix): nmax = 3082,
AHCTUNGTRENNUNG
CDCl3/TMS + 2% v/v [D5]pyridine): d = 8.77 (brs, 8H, b-pyrrolic H),
8.14 (d, J=7.5 Hz, 8H, phenyl Ho), 7.67 (brm, 4H, triazole Ar-H), 7.53
(d, J=7.5 Hz, phenyl 8H, Hm), 7.25–6.25 (brm, 400H, polystyrene Ar-
H), 5.78 (brm, 8H, triazole-HNa), 5.12 (brm, 8H, triazole-HCa), 4.90–4.71
(brm, 4H, -CH-SCS2-), 3.25 (brs, 8H, -SCH2CH2-), 1.86–1.08 (brm,
3060, 3024, 2924, 1945, 1866, 1803, 1735, 1601, 1493, 1452, 1369, 1154,
1068, 1028, 998, 905, 758, 698 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 312
(4.36), 393 (4.30), 413 (5.37), 451 (3.40), 506 (3.34), 543 (4.02), 580 (3.34),
633 nm (2.89).
(PBA15)4–Zn:
Mn,GPC
(THF)=9190 gmolꢀ1
;
ꢀ=1.24;
1H NMR
238H, backbone -CH2CH- and -S-CH
2ACHTUGNTREN[UNGN CH2]CH3), 0.90 ppm (brm, 24H,
(500 MHz, CDCl3/TMS + 2% v/v [D5]pyridine): d = 8.72 (s, 8H, b-pyr-
rolic H), 8.10 (d, J=7.0 Hz, 8H, phenyl Ho), 7.84 (brm, 4H, triazole Ar-
H), 7.54 (d, J=7.4 Hz, 8H, phenyl, Hm), 5.82 (d, J=6.15 Hz, 8H, tria-
zole-HNa), 5.25 (brm, 8H, triazole-HCa), 4.75 (brm, 4H, -CH-SCS2), 3.97
(brs, 120H, butyl acrylate a-CH2), 3.27 (t, J=7.5 Hz, 8H, -SCH2CH2-),
-S(CH2)3-CH3 and -O(C=O)CHCH3); IR (DRIFTS, KBr matrix): nmax =
A
U
3079, 3061, 3025, 2924, 2852, 1944, 1873, 1804, 1734, 1601, 1493, 1450,
1157, 1028, 906, 756, 698, 540 cmꢀ1; UV/Vis (THF): lmax (log10(e)) = 311
(4.76), 404 (4.57), 425 (5.66), 486 (3.26), 517 (3.50), 557 (4.25), 595 (3.82),
643 nm (2.6).
2.54–1.17 (brm, 436H, backbone -CH2CH- and -S-CH2ACHTNUGTRNEUNG[CH2]CH3 and
&
10
&
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!